Molecular engineering of safe and efficacious oral basal insulin von Hubálek, Frantisek, Refsgaard, Hanne H. F., Gram-Nielsen, Sanne, Madsen, Peter, Nishimura, Erica, Münzel, Martin, Brand, Christian Lehn, Stidsen, Carsten Enggaard, Claussen, Christian Hove, Wulff, Erik Max, Pridal, Lone, Ribel, Ulla, Kildegaard, Jonas, Porsgaard, Trine, Johansson, Eva, Steensgaard, Dorte Bjerre, Hovgaard, Lars, Glendorf, Tine, Hansen, Bo Falck, Jensen, Maja Kirkegaard, Nielsen, Peter Kresten, Ludvigsen, Svend, Rugh, Susanne, Garibay, Patrick W., Moore, Mary Courtney, Cherrington, Alan D., Kjeldsen, Thomas

Volltext

Pharmacokinetic/pharmacodynamic modeling of drug interactions at the P2Y12 receptor between selatogrel and oral P2Y12 antagonists von Henrich, Andrea, Claussen, Christian Hove, Dingemanse, Jasper, Krause, Andreas

Volltext

Author Correction: Molecular engineering of safe and efficacious oral basal insulin von Hubálek, Frantisek, Refsgaard, Hanne H. F., Gram-Nielsen, Sanne, Madsen, Peter, Nishimura, Erica, Münzel, Martin, Brand, Christian Lehn, Stidsen, Carsten Enggaard, Claussen, Christian Hove, Wulff, Erik Max, Pridal, Lone, Ribel, Ulla, Kildegaard, Jonas, Porsgaard, Trine, Johansson, Eva, Steensgaard, Dorte Bjerre, Hovgaard, Lars, Glendorf, Tine, Hansen, Bo Falck, Jensen, Maja Kirkegaard, Nielsen, Peter Kresten, Ludvigsen, Svend, Rugh, Susanne, Garibay, Patrick W., Moore, Mary Courtney, Cherrington, Alan D., Kjeldsen, Thomas

Volltext

Pharmacokinetic/pharmacodynamic modeling of drug interactions at the P2Y 12 receptor between selatogrel and oral P2Y 12 antagonists von Henrich, Andrea, Claussen, Christian Hove, Dingemanse, Jasper, Krause, Andreas

Volltext

Molecular engineering of safe and efficacious oral basal insulin (vol 11, pg 3746, 2020) von Hubalek, Frantisek, Refsgaard, Hanne H. F., Gram-Nielsen, Sanne, Madsen, Peter, Nishimura, Erica, Munzel, Martin, Brand, Christian Lehn, Stidsen, Carsten Enggaard, Claussen, Christian Hove, Wulff, Erik Max, Pridal, Lone, Ribel, Ulla, Kildegaard, Jonas, Porsgaard, Trine, Johansson, Eva, Steensgaard, Dorte Bjerre, Hovgaard, Lars, Glendorf, Tine, Hansen, Bo Falck, Jensen, Maja Kirkegaard, Nielsen, Peter Kresten, Ludvigsen, Svend, Rugh, Susanne, Garibay, Patrick W., Moore, Mary Courtney, Cherrington, Alan D., Kjeldsen, Thomas

Volltext

Abstract CT025: NMS-03592088, a novel, potent FLT3, KIT and CSF1R inhibitor with activity in FLT3 positive acute myeloid leukemia patients with prior FLT3 inhibitor experience von Curti, Antonio, Rambaldi, Alessandro, Cattaneo, Chiara, Cairoli, Roberto, Porta, Matteo Della, Chiusolo, Patrizia, Lussana, Federico, Ubezio, Marta, Mancini, Valentina, Cano, Isabel, Besliu, Carmen, Claussen, Christian Hove, Gatto, Rosalinda, Crivori, Patrizia, Colajori, Elena, Somaschini, Alessio, Davite, Cristina, Isacchi, Antonella, Ardini, Elena, Mahnke, Lisa, Montesinos, Pau

Volltext

Author Correction: Molecular engineering of safe and efficaciousoral basal insulin von Hubálek Frantisek, Refsgaard Hanne H F, Gram-Nielsen, Sanne, Madsen, Peter, Nishimura, Erica, Münzel, Martin, Brand, Christian Lehn, Stidsen, Carsten Enggaard, Claussen, Christian Hove, Wulff, Erik Max, Pridal Lone, Ribel Ulla, Kildegaard Jonas, Porsgaard Trine, Johansson, Eva, Steensgaard, Dorte Bjerre, Hovgaard Lars, Glendorf Tine, Hansen, Bo Falck, Jensen, Maja Kirkegaard, Nielsen, Peter Kresten, Ludvigsen Svend, Rugh, Susanne, Garibay, Patrick W, Moore, Mary Courtney, Cherrington, Alan D, Kjeldsen, Thomas

Volltext